23 results for author:"Sgroi D.C." in Literature citations
Results Customize
› Repeat search in UniProtKB (8)
| Predisposition to cancer caused by genetic and functional defects of mammalian Atad5. Bell D.W., Sikdar N., Lee K.Y., Price J.C., Chatterjee R., Park H.D., Fox J., Ishiai M., Rudd M.L., Pollock L.M. et al. PLoS Genet. 7:e1002245-e1002245(2011) · UniProtKB (1) · Mapped (2) |
| The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway. Jin K., Kong X., Shah T., Penet M.F., Wildes F., Sgroi D.C., Ma X.J., Huang Y., Kallioniemi A., Landberg G. et al. Proc. Natl. Acad. Sci. U.S.A. 109:2736-2741(2012) · Mapped (22) |
| A unique spectrum of somatic PIK3CA (p110alpha) mutations within primary endometrial carcinomas. Rudd M.L., Price J.C., Fogoros S., Godwin A.K., Sgroi D.C., Merino M.J., Bell D.W. Clin. Cancer Res. 17:1331-1340(2011) · Mapped (7) |
| Prevalence and functional analysis of sequence variants in the ATR checkpoint mediator Claspin. Zhang J., Song Y.H., Brannigan B.W., Wahrer D.C., Schiripo T.A., Harris P.L., Haserlat S.M., Ulkus L.E., Shannon K.M., Garber J.E. et al. Mol. Cancer Res. 7:1510-1516(2009) · Mapped (3) |
| Utility of DNA repair protein foci for the detection of putative BRCA1 pathway defects in breast cancer biopsies. Willers H., Taghian A.G., Luo C.M., Treszezamsky A., Sgroi D.C., Powell S.N. Mol. Cancer Res. 7:1304-1309(2009) · Mapped (6) |
| Cytochrome P450 2D6 and homeobox 13/interleukin-17B receptor: combining inherited and tumor gene markers for prediction of tamoxifen resistance. Goetz M.P., Suman V.J., Couch F.J., Ames M.M., Rae J.M., Erlander M.G., Ma X.J., Sgroi D.C., Reynolds C.A., Lingle W.L. et al. Clin. Cancer Res. 14:5864-5868(2008) · Mapped (20) |
| Identification and rational redesign of peptide ligands to CRIP1, a novel biomarker for cancers. Hao J., Serohijos A.W., Newton G., Tassone G., Wang Z., Sgroi D.C., Dokholyan N.V., Basilion J.P. PLoS Comput. Biol. 4:e1000138-e1000138(2008) · Mapped (3) |
| The prognostic biomarkers HOXB13, IL17BR, and CHDH are regulated by estrogen in breast cancer. Wang Z., Dahiya S., Provencher H., Muir B., Carney E., Coser K., Shioda T., Ma X.J., Sgroi D.C. Clin. Cancer Res. 13:6327-6334(2007) · Mapped (4) |
| HOXB13 promotes ovarian cancer progression. Miao J., Wang Z., Provencher H., Muir B., Dahiya S., Carney E., Leong C.O., Sgroi D.C., Orsulic S. Proc. Natl. Acad. Sci. U.S.A. 104:17093-17098(2007) · Mapped (2) |
| Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts. Bell D.W., Kim S.H., Godwin A.K., Schiripo T.A., Harris P.L., Haserlat S.M., Wahrer D.C., Haiman C.A., Daly M.B., Niendorf K.B. et al. Int. J. Cancer 121:2661-2667(2007) · Mapped (3) |
| A Rap GTPase interactor, RADIL, mediates migration of neural crest precursors. Smolen G.A., Schott B.J., Stewart R.A., Diederichs S., Muir B., Provencher H.L., Look A.T., Sgroi D.C., Peterson R.T., Haber D.A. |
| The Spemann organizer gene, Goosecoid, promotes tumor metastasis. Hartwell K.A., Muir B., Reinhardt F., Carpenter A.E., Sgroi D.C., Weinberg R.A. Proc. Natl. Acad. Sci. U.S.A. 103:18969-18974(2006) · Mapped (1) |
| The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer. Ma X.J., Hilsenbeck S.G., Wang W., Ding L., Sgroi D.C., Bender R.A., Osborne C.K., Allred D.C., Erlander M.G. J. Clin. Oncol. 24:4611-4619(2006) · Mapped (2) |
| Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Overholtzer M., Zhang J., Smolen G.A., Muir B., Li W., Sgroi D.C., Deng C.X., Brugge J.S., Haber D.A. Proc. Natl. Acad. Sci. U.S.A. 103:12405-12410(2006) · Mapped (14) |
| Epidermal growth factor receptor kinase domain mutations in esophageal and pancreatic adenocarcinomas. Kwak E.L., Jankowski J., Thayer S.P., Lauwers G.Y., Brannigan B.W., Harris P.L., Okimoto R.A., Haserlat S.M., Driscoll D.R., Ferry D. et al. Clin. Cancer Res. 12:4283-4287(2006) · Mapped (19) |
| A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen. Goetz M.P., Suman V.J., Ingle J.N., Nibbe A.M., Visscher D.W., Reynolds C.A., Lingle W.L., Erlander M., Ma X.J., Sgroi D.C. et al. Clin. Cancer Res. 12:2080-2087(2006) · Mapped (2) |
| Frequent met oncogene amplification in a Brca1/Trp53 mouse model of mammary tumorigenesis. Smolen G.A., Muir B., Mohapatra G., Barmettler A., Kim W.J., Rivera M.N., Haserlat S.M., Okimoto R.A., Kwak E., Dahiya S. et al. Cancer Res. 66:3452-3455(2006) · Mapped (35) |
| Novel role for PDEF in epithelial cell migration and invasion. Gunawardane R.N., Sgroi D.C., Wrobel C.N., Koh E., Daley G.Q., Brugge J.S. Cancer Res. 65:11572-11580(2005) · Mapped (1) |
| Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Orimo A., Gupta P.B., Sgroi D.C., Arenzana-Seisdedos F., Delaunay T., Naeem R., Carey V.J., Richardson A.L., Weinberg R.A. Cell 121:335-348(2005) · Mapped (2) |
| Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis. Reginato M.J., Mills K.R., Paulus J.K., Lynch D.K., Sgroi D.C., Debnath J., Muthuswamy S.K., Brugge J.S. Nat. Cell Biol. 5:733-740(2003) · Mapped (22) |
| Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation. Talora C., Sgroi D.C., Crum C.P., Dotto G.P. Genes Dev. 16:2252-2263(2002) · Mapped (3) |
| Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome. Lee S.B., Kim S.H., Bell D.W., Wahrer D.C.R., Schiripo T.A., Jorczak M.M., Sgroi D.C., Garber J.E., Li F.P., Nichols K.E. et al. |
| BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cantor S.B., Bell D.W., Ganesan S., Kass E.M., Drapkin R., Grossman S., Wahrer D.C.R., Sgroi D.C., Lane W.S., Haber D.A. et al. |